Financial News
ANGLE PLC has opened up "a major market opportunity" with breast cancer partnership
--News Direct--
ANGLE PLC (AIM:AGL, OTCQX:ANPCY) chief executive Andrew Newland joins Thomas Warner from Proactive after announcing a development partnership with BioView.
The partnership will see the two firms develop to create a circulating tumour cell (CTC) HER2 assay for breast cancer that could ultimately enable hospitals worldwide to access technology that measures HER2 status in breast cancer patients.
Newlands says it has opened up "a major market opportunity" with the partnership.
Contact Details
Proactive UK Ltd
Proactive UK Ltd
+44 20 7989 0813
View source version on newsdirect.com: https://newsdirect.com/news/angle-plc-has-opened-up-a-major-market-opportunity-with-breast-cancer-partnership-730080164
If you believe this article contains misleading, harmful, or spam content, please let us know.
Report this articleMore News
View More
Recent Quotes
View MoreQuotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
